Coverage
-
November 16, 2012
A Washington federal judge on Thursday nixed Novartis AG's bid to extend the life on 19 of its patents, ruling the drugmaker waited too long before challenging the U.S. Patent and Trademark Office's patent term adjustment calculations.
2 other articles on this case.
View all »